Search Results

Site Search

Malabsorption panel - Insights

Mayo Clinic Laboratories, which is integrated with the clinical gastroenterology practice at Mayo Clinic, understands the worry patients and their loved ones feel while awaiting test results. To expedite and streamline the diagnostic...

Creatine disorders - Insights

Check out Mayo Clinic Laboratories’ biochemical and molecular testing options to diagnose creatine deficiency disorders.

Purine and pyrimidine metabolism disorders - Insights

Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.

Advanced Phlebotomy Collections - Insights

Find out about advanced blood collection techniques and the specialized procedures that are used when standard blood collection methods may not be feasible or when specific tests require more specialized handling of blood samples.

Safety in Phlebotomy - Insights

Get a general introduction to safety precautions, which will help ensure the well-being of you and your patients.

Specimen Integrity and Processing - Insights

Learn about the variables influencing successful blood draws and their potential impact on laboratory outcomes, Quality Assurance principles, the regulatory agencies ensuring patient and healthcare worker safety, and the organizational...

Difficult Collections and Special Populations - Insights

Get an overview of phlebotomy techniques for pediatric and geriatric patients who often present as unique challenges due to their physiological and anatomical differences.

Neuromuscular panel - Insights

Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.

Other neuromuscular disorders - Insights

Learn how our comprehensive menu of focused panels can provide clarity and confidence when diagnosing neuromuscular disorders.

Frontotemporal dementia and ALS - Insights

Learn more about how detection of amyotrophic lateral sclerosis and frontotemporal dementia paved the way for gene-targeted therapies for patients.